Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript

2025-03-28 13:48:49 ET

Humacyte, Inc. (HUMA)

Q4 2024 Earnings Conference Call

March 27, 2025, 08:30 AM ET

Company Participants

Thomas Johnson - Director, Corporate Communications, LifeSci Advisors, IR

Laura Niklason - President and CEO

Dale Sander - CFO and Chief Corporate Development Officer

Conference Call Participants

Josh Jennings - TD Cowen & Company

Ryan Zimmerman - BTIG

Vernon Bernardino - H.C. Wainwright

Bruce Jackson - Benchmark Company

Presentation

Operator

Good morning, ladies and gentlemen. Welcome to the Humacyte Fourth Quarter Results Conference Call. Currently all participants are in listen-only mode. Later we'll conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call is being recorded.

I'll now turn the call over to Tom Johnson with LifeSci Advisors. Please go ahead, sir.

Thomas Johnson

Thank you, operator.

Before we proceed with today's call, I would like to remind everyone that certain statements made during the call are forward-looking statements under U.S. Federal Securities Laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call are contained in our periodic reports filed with the SEC.

The forward-looking statements made during this call speak only as the date hereof, and the company undertakes no obligation to update or revise forward-looking statements, except required by law. Information presented on this call contained in the press release we issued this morning and in our Form 10-K, which after filing may be accessed from the Investor page of the Humacyte website....

Read the full article on Seeking Alpha

For further details see: